Clinical presentation and opportunistic infections in HIV-1, HIV-2 and HIV-1/2 dual seropositive patients in Guinea-Bissau

References

• da Silva ZJ, Oliveira I, Andersen A, et al. Changes in prevalence and incidence of HIV-1, HIV-2 and dual infections in urban areas of Bissau, Guinea-Bissau: is HIV-2 disappearing? AIDS. 2008;22:1195–1202.
   PubMed Web of Science ®Google Scholar
• Poulsen AG, Aaby P, Gottschau A, et al. HIV-2 infection in Bissau, West Africa, 1987–1989: incidence, prevalences, and routes of transmission. J Acquir Immune Defic Syndr. 1993;6:941–948.
   PubMed Web of Science ®Google Scholar
• Poulsen AG, Aaby P, Larsen O, et al. 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet. 1997;349:911–914.
   PubMed Web of Science ®Google Scholar
• Schim van der Loeff MF, Aaby P. Towards a better understanding of the epidemiology of HIV-2. AIDS. 1999;13:S69–S84.
   PubMed Web of Science ®Google Scholar
• Hansmann A, Schim van der Loeff MF, Kaye S, et al. Baseline plasma viral load and CD4 cell percentage predict survival in HIV-1- and HIV-2-infected women in a community-based cohort in The Gambia. J Acquir Immune Defic Syndr. 2005;38:335–341.
   PubMed Web of Science ®Google Scholar
• Oliveira I, Andersen A, Furtado A, et al. Assessment of simple risk markers for early mortality among HIV-infected patients in Guinea-Bissau: a cohort study. BMJ Open. 2012;2: e001587.
   PubMed Web of Science ®Google Scholar
• Schim van der Loeff MF, Jaffar S, Aveika AA, et al. Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS. 2002;16:1775–1783.
   PubMed Web of Science ®Google Scholar
• De Cock KM, Odehouri K, Colebunders RL, et al . A comparison of HIV-1 and HIV-2 infections in hospitalized patients in Abidjan, Côte d'Ivoire. AIDS. 1990;4:443–448.
   PubMed Web of Science ®Google Scholar
• Le Guenno BM, Barabe P, Griffet PA, et al. HIV-2 and HIV-1 AIDS cases in Senegal: clinical patterns and immunological perturbations. J Acquir Immune Defic Syndr. 1991;4:421–427.
   PubMed Web of Science ®Google Scholar
• Ndour M, Sow PS, Coll‐seck AM, et al. AIDS caused by HIV1 and HIV2 infection: are there clinical differences? Results of AIDS surveillance 1986–97 at Fann Hospital in Dakar, Senegal. Trop Med Int Health. 2000;5:687–691.
   PubMed Web of Science ®Google Scholar
• Ekouevi DK, Balestre E, Coffie PA, et al. Characteristics of HIV-2 and HIV-1/HIV-2 dually seropositive adults in West Africa presenting for care and antiretroviral therapy: the IeDEA-West Africa HIV-2 Cohort Study. PLoS One. 2013;8:e66135.
   Google Scholar
• Hønge BL, Jespersen S, Medina C, et al. Hepatitis C prevalence among HIV-infected patients in Guinea-Bissau: a descriptive cross-sectional study. Int J Infect Dis. 2014;28:35–40.
   PubMed Web of Science ®Google Scholar
• Hønge BL, Jespersen S, Medina C, et al. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. PLoS One. 2014;9:e99971.
   Google Scholar
• Hønge B, Jespersen S, Medina C, et al. Hepatitis B virus surface antigen and anti-hepatitis C virus rapid tests underestimate hepatitis prevalence among HIV-infected patients. HIV Med. 2014;15:571–576.
   PubMed Web of Science ®Google Scholar
• Jespersen S, Hønge BL, Oliveira I, et al. Cohort profile: the Bissau HIV cohort-a cohort of HIV-1, HIV-2 and co-infected patients. Int J Epidemiol. 2015;44:756–763.
   PubMed Web of Science ®Google Scholar
• Jespersen S, Hønge BL, Oliveira I, et al. Challenges facing HIV treatment in Guinea-Bissau: the benefits of international research collaborations. Bull World Health Organ. 2014;92:909–914.
   PubMed Web of Science ®Google Scholar
• Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec. 1990;65:221–224.
   PubMedGoogle Scholar
• Harries K, Zachariah R, Manzi M, et al. Baseline characteristics, response to and outcome of antiretroviral therapy among patients with HIV-1, HIV-2 and dual infection in Burkina Faso. Trans R Soc Trop Med Hyg. 2010;104:154–161.
   PubMed Web of Science ®Google Scholar
• Martinez-Steele E, Awasana AA, Corrah T, et al. Is HIV-2- induced AIDS different from HIV-1-associated AIDS? Data from a West African clinic. AIDS. 2007;21:317–324.
   PubMed Web of Science ®Google Scholar
• Hønge BL, Bjarnason Obinah MP, Jespersen S, et al. Performance of 3 rapid tests for discrimination between HIV-1 and HIV-2 in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr. 2014;65:87–90.
   PubMed Web of Science ®Google Scholar
• Hønge BL, Jespersen S, Bjarnason Obinah MP, et al. Interobserver variation of the rapid test SD bioline HIV-1/2 3.0 for HIV type discrimination: experiences from Guinea-Bissau. J Acquir Immune Defic Syndr. 2015;68:e23–e25.
   Google Scholar
• Hønge BL, Jespersen S, Nordentoft PB, et al. Loss to follow-up occurs at all stages in the diagnostic and follow-up period among HIV-infected patients in Guinea-Bissau: a 7-year retrospective cohort study. BMJ Open. 2013;3:e003499.
   PubMed Web of Science ®Google Scholar
• Rasmussen DN, da Silva Té D, Rodkjaer L, et al. Barriers and facilitators to antiretroviral therapy adherence among patients with HIV in Bissau, Guinea-Bissau: A qualitative study. Afr J AIDS Res. 2013;12:1–8.
   PubMed Web of Science ®Google Scholar
• Poulsen AG, Aaby P, Jensen H, et al. Risk factors for HIV-2 seropositivity among older people in Guinea-Bissau. A search for the early history of HIV-2 infection. Scand J Infect Dis. 2000;32:169–175.
   PubMedGoogle Scholar
• Wilkins A, Ricard D, Todd J, et al. The epidemiology of HIV infection in a rural area of Guinea-Bissau. AIDS. 1993;7:1119–1122.
   PubMed Web of Science ®Google Scholar
• De Cock KM, Adjorlolo G, Ekpini E, et al. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA. 1993;270:2083–2086.
   PubMed Web of Science ®Google Scholar
• Holmgren B, da Silva Z, Vastrup P, et al. Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology. 2007;4:85.
   PubMed Web of Science ®Google Scholar
• Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science. 1994;265:1587–1590.
   PubMed Web of Science ®Google Scholar
• Reid A, Stöhr W, Walker AS, et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008;46:1271–1281.
   PubMed Web of Science ®Google Scholar
• Travers K, Mboup S, Marlink R, et al. Natural protection against HIV-1 infection provided by HIV-2. Science. 1995;268:1612–1615.
   PubMed Web of Science ®Google Scholar
• Esbjörnsson J, Månsson F, Kvist A, et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med. 2012;367:224–232.
   PubMed Web of Science ®Google Scholar
• Prince PD, Matser A, van Tienen C, et al. Mortality rates in people dually infected with HIV-1/2 and those infected with either HIV-1 or HIV-2: a systematic review and meta-analysis. AIDS. 2014;28:549–558.
   PubMed Web of Science ®Google Scholar
• Raviglione MC, Harries AD, Msiska R, et al. Tuberculosis and HIV: current status in Africa. AIDS. 1997;11:S115–S123.
   PubMedGoogle Scholar
• van der Sande MA, Schim van der Loeff MF, Bennett RC, et al. Incidence of tuberculosis and survival after its diagnosis in patients infected with HIV-1 and HIV-2. AIDS. 2004;18:1933–1941.
   PubMed Web of Science ®Google Scholar
• Seng R, Gustafson P, Gomes VF, et al. Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis. AIDS 2002;16:1059–1066.
   PubMed Web of Science ®Google Scholar
• Wood R, Middelkoop K, Myer L, et al. Undiagnosed tuberculosis in a community with high HIV prevalence: Implications for tuberculosis control. Am J Respir Crit Care Med. 2007;175:87–93.
   PubMed Web of Science ®Google Scholar
• Lewden C, Drabo YJ, Zannou DM, et al. Disease patterns and causes of death of hospitalized HIV-positive adults in West Africa: a multicountry survey in the antiretroviral treatment era. J Int AIDS Soc. 2014;17:18797. doi:http://dx.doi.org/10.7448/IAS.17.1.18797
   PubMed Web of Science ®Google Scholar